Adage Capital Partners’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-276,000
Closed -$3.19M 898
2025
Q1
$3.19M Sell
276,000
-24,000
-8% -$277K 0.01% 736
2024
Q4
$2.54M Sell
300,000
-1,119,792
-79% -$9.48M ﹤0.01% 777
2024
Q3
$16.4M Sell
1,419,792
-630,208
-31% -$7.3M 0.03% 502
2024
Q2
$24.1M Sell
2,050,000
-525,000
-20% -$6.18M 0.04% 383
2024
Q1
$30.5M Buy
2,575,000
+1,870,000
+265% +$22.2M 0.06% 351
2023
Q4
$8.64M Sell
705,000
-351,691
-33% -$4.31M 0.02% 611
2023
Q3
$10.2M Sell
1,056,691
-47,648
-4% -$459K 0.02% 557
2023
Q2
$9.94M Buy
1,104,339
+40,000
+4% +$360K 0.02% 574
2023
Q1
$8.37M Hold
1,064,339
0.02% 646
2022
Q4
$7.19M Sell
1,064,339
-15,000
-1% -$101K 0.02% 706
2022
Q3
$15.7M Sell
1,079,339
-25,000
-2% -$363K 0.04% 496
2022
Q2
$10.9M Buy
1,104,339
+200,000
+22% +$1.97M 0.02% 651
2022
Q1
$13.3M Buy
904,339
+20,000
+2% +$295K 0.03% 611
2021
Q4
$11.7M Hold
884,339
0.02% 653
2021
Q3
$15.4M Sell
884,339
-661
-0.1% -$11.5K 0.03% 557
2021
Q2
$21.2M Buy
885,000
+80,000
+10% +$1.92M 0.04% 447
2021
Q1
$20.7M Buy
805,000
+505,000
+168% +$13M 0.04% 437
2020
Q4
$5.7M Sell
300,000
-100,000
-25% -$1.9M 0.01% 676
2020
Q3
$5.04M Hold
400,000
0.01% 636
2020
Q2
$4.84M Hold
400,000
0.01% 627
2020
Q1
$3.06M Sell
400,000
-100,000
-20% -$765K 0.01% 626
2019
Q4
$8.91M Sell
500,000
-200,000
-29% -$3.56M 0.02% 555
2019
Q3
$8.12M Hold
700,000
0.02% 557
2019
Q2
$15.5M Buy
700,000
+35,000
+5% +$775K 0.04% 425
2019
Q1
$19M Buy
665,000
+65,000
+11% +$1.86M 0.05% 392
2018
Q4
$11.9M Buy
600,000
+294,813
+97% +$5.82M 0.03% 465
2018
Q3
$6.75M Buy
+305,187
New +$6.75M 0.02% 603